Convergence Research Platform for the Precision Medicine in the Treatment of Inflammatory Bowel Disease
试验速览
- 阶段
- 不适用
- 状态
- Enrolling By Invitation
- 入组人数
- 2,000
- 试验地点
- 1
- 主要终点
- Prediction model in the patients with inflammatory bowel disease for treatment response
研究概览
简要总结
This study aims to establish an integrated cohort of patients with inflammatory bowel disease (IBD) from Seoul National University Hospital, Seoul National University Boramae Medical Center, and Seoul National University Bundang Hospital. Through this cohort, we seek to develop a prognostic prediction model for IBD patients and a predictive model for therapeutic responses to biologic agents and small molecule therapies.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 10 Years 至 —（Child, Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients aged 10 years or older who have been newly diagnosed with inflammatory bowel disease or are under follow-up monitoring.
排除标准
- •Patients diagnosed with cancer or with a history of cancer treatment.
- •Participation may be restricted at the discretion of the medical team.
- •Infants and young children under the age of 10.
结局指标
主要结局
Prediction model in the patients with inflammatory bowel disease for treatment response
时间窗: From enrollment to the end of treatment at 12 weeks
Development of a prognostic prediction model for patients with inflammatory bowel disease and a predictive model for therapeutic response to biologic agents and small molecule therapies
次要结局
未报告次要终点
研究者
SeongJoon Koh
Professor
Seoul National University Hospital